InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,442.00
(
2.14%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,136.80
(
0.38%
)
Post# of 97
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

MWM

Send PM Follow Ignore
Followers 1062
Posts 141580
Boards Moderated 14
Alias Born 03/31/2006

MWM

Re: None

Thursday, 12/10/2020 6:51:59 AM

Thursday, December 10, 2020 6:51:59 AM

Post# of 97
Greenwich has been working on its GP2 immunotherapy to prevent recurrences of breast cancer in patients who have previously undergone surgery. A phase 2b trial showed evidence of greater disease-free survival rates for those taking GP2 in combination with other drugs compared to patients taking only the other drugs. Indeed, the trial involving 138 patients showed no recurrences at all for the GP2 group.

Armed with these results, Greenwich is now looking to find clinical trial partners to move forward with a phase 3 trial. The move higher for the stock has been a big win for investors in Greenwich's IPO, which happened less than three months ago.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GLSI News
More GLSI News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!